Chronic hepatitis C – what do the new drugs offer and who should get them first?

por Ryder, Stephen D
Publicado no Clin Med (Lond) (2015)

Screening for hepatocellular carcinoma: patient selection and perspectives

por Fateen, Waleed, Ryder, Stephen D
Publicado no J Hepatocell Carcinoma (2017)

Epistaxis: an overlooked cause of massive haematemesis in cirrhosis

por Johal, Shawinder S, Austin, Andrew S, Ryder, Stephen D
Publicado em 2003

Biochemical “liver function tests”

por Smellie, W Stuart A, Ryder, Stephen D
Publicado em 2006

The Utility of Scoring Systems in Predicting Early and Late Mortality in Alcoholic Hepatitis: Whose Score Is It Anyway?

por Palaniyappan, Naaventhan, Subramanian, Venkataraman, Ramappa, Vidyasagar, Ryder, Stephen D., Kaye, Philip, Aithal, Guruprasad P.
Publicado em 2012

Getting involved in clinical trials research in the UK: how can Clinical Research Networks help?

por Hull, Mark A, Yiannakou, Yan, Gower, Jonathan, Ryder, Stephen D, Bloom, Stuart L, Rees, Colin R
Publicado no Frontline Gastroenterol (2012)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma

por Fateen, Waleed, Khan, Farooq, O’NeiSSll, Richard J, James, Martin W, Ryder, Stephen D, Aithal, Guruprasad P
Publicado no J Hepatocell Carcinoma (2017)

The Utility of Liver Function Tests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI)

por McLernon, David J., Dillon, John F., Sullivan, Frank M., Roderick, Paul, Rosenberg, William M., Ryder, Stephen D., Donnan, Peter T.
Publicado em 2012

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography

por Harman, David J, Ryder, Stephen D, James, Martin W, Jelpke, Matthew, Ottey, Dominic S, Wilkes, Emilie A, Card, Timothy R, Aithal, Guruprasad P, Guha, Indra Neil
Publicado no BMJ Open (2015)

Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018

por Morgan, Alice, Hartmanis, Sally, Tsochatzis, Emmanuel, Newsome, Philip N., Ryder, Stephen D., Elliott, Rachel, Floros, Lefteris, Hall, Richard, Higgins, Victoria, Stanley, George, Cure, Sandrine, Vasudevan, Sharad, Pezzullo, Lynne
Publicado no Eur J Health Econ (2021)

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective coh...

por Lampertico, Pietro, Berg, Thomas, Buti, Maria, Pathil, Anita, Petersen, Joerg, Ryder, Stephen D., Zoulim, Fabien, Botros, Irina, Flaherty, John F., Jump, Belinda, Op den Brouw, Marjoleine L., van Troostenburg, Anna, Ramroth, Heribert
Publicado no Aliment Pharmacol Ther (2020)

In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of B...

por Vergis, Nikhil, Atkinson, Stephen R., Knapp, Suzanne, Maurice, James, Allison, Michael, Austin, Andrew, Forrest, Ewan H., Masson, Steven, McCune, Anne, Patch, David, Richardson, Paul, Gleeson, Dermot, Ryder, Stephen D., Wright, Mark, Thursz, Mark R.
Publicado no Gastroenterology (2017)

The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)

por Hudson, Mark, Radwan, Amr, Di Maggio, Paola, Cipelli, Riccardo, Ryder, Stephen D, Dillon, John F, Cash, William Jonathan, Przemioslo, Robert T, Wright, Mark, Shawcross, Debbie L, Jalan, Rajiv, Saksena, Sushma, Allison, Michael, Richardson, Paul, Farrington, Elizabeth, Aspinall, Richard J
Publicado no Frontline Gastroenterol (2017)

NI‐0801, an anti‐chemokine (C‐X‐C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid

por de Graaf, Kathy L., Lapeyre, Geneviève, Guilhot, Florence, Ferlin, Walter, Curbishley, Stuart M., Carbone, Marco, Richardson, Paul, Moreea, Sulleman, McCune, C. Anne, Ryder, Stephen D., Chapman, Roger W., Floreani, Annarosa, Jones, David E., de Min, Cristina, Adams, David H., Invernizzi, Pietro
Publicado no Hepatol Commun (2018)

Long-term outcomes of liver transplant recipients followed up in non-transplant centres: Care closer to home

por Tsien, Cynthia, Tan, Huey, Sharma, Sowmya, Palaniyappan, Naaventhan, Wijayasiri, Pramudi, Leung, Kristel, Hayre, Jatinder, Mowlem, Elizabeth, Kang, Rachel, Eddowes, Peter J, Wilkes, Emilie, Venkatachalapathy, Suresh V, Guha, Indra N, Antonova, Lilia, Cheung, Angela C, Griffiths, William JH, Butler, Andrew J, Ryder, Stephen D, James, Martin W, Aithal, Guruprasad P, Aravinthan, Aloysious D
Publicado no Clin Med (Lond) (2021)

Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis

por Flamm, Steven, Mutimer, David, Asatryan, Armen, Wang, Stanley, Rockstroh, Jürgen, Horsmans, Yves, Kwo, Paul Y., Weiland, Ola, Villa, Erica, Heo, Jeong, Gane, Edward, Ryder, Stephen D., Welzel, Tania M., Ruane, Peter J., Agarwal, Kosh, Ng, Teresa I., Xue, Zhenyi, Lovell, Sandra S., Krishnan, Preethi, Kopecky‐Bromberg, Sarah, Trinh, Roger, Mensa, Federico J., Wyles, David L.
Publicado no J Viral Hepat (2018)

Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

por Schattenberg, Jörn M., Lazarus, Jeffrey V., Newsome, Philip N., Serfaty, Lawrence, Aghemo, Alessio, Augustin, Salvador, Tsochatzis, Emmanuel, de Ledinghen, Victor, Bugianesi, Elisabetta, Romero‐Gomez, Manuel, Bantel, Heike, Ryder, Stephen D., Boursier, Jerome, Leroy, Vincent, Crespo, Javier, Castera, Laurent, Floros, Lefteris, Atella, Vincenzo, Mestre‐Ferrandiz, Jorge, Elliott, Rachel, Kautz, Achim, Morgan, Alice, Hartmanis, Sally, Vasudevan, Sharad, Pezzullo, Lynne, Trylesinski, Aldo, Cure, Sandrine, Higgins, Victoria, Ratziu, Vlad
Publicado no Liver Int (2021)